Key facts
- This page summarizes J. E. Davis's Form 4 filing for QUEST DIAGNOSTICS INC (DGX).
- 5 reported transactions and 1 derivative row are listed below.
- Filing timestamp: 28 Nov 2025, 16:30.
J. E. Davis - 25 Nov 2025 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)
- Signature
- Sean D. Mersten, Attorney in Fact for James E. Davis
- Issuer symbol
- DGX
- Transactions as of
- 25 Nov 2025
- Net transactions value
- -$10,589,760
- Form type
- 4
- Filing time
- 28 Nov 2025, 16:30:50 UTC
- Previous filing
- 07 Nov 2025
- Next filing
- 20 Feb 2026
- SEC
- View on sec.gov
Key filing fact
J. E. Davis filed Form 4 for QUEST DIAGNOSTICS INC (DGX) on 28 Nov 2025.
Change
- Previous filing in this sequence was filed on 07 Nov 2025.
- Current net transaction value: -$10,589,760.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001599837
Primary reporting owner
Davis J. E.
- Relationship
- CEO and President, Director
- Address
- 500 PLAZA DRIVE, SECAUCUS
- Signature
- Sean D. Mersten, Attorney in Fact for James E. Davis
- Signature date
- 28 Nov 2025
Transactions Table
DGX
transaction
Common Stock
Options Exercise
- Transaction value
- $5,277,634
- Shares
- +55,093
- Change %
- +46%
- Price
- $95.80
- Shares after
- 175,573
- Date
- 25 Nov 2025
- Ownership
- Direct
- Footnotes
- F1
DGX
transaction
Common Stock
Sale
- Transaction value
- $1,789,823
- Shares
- -9,342
- Change %
- -5.3%
- Price
- $191.59
- Shares after
- 166,231
- Date
- 25 Nov 2025
- Ownership
- Direct
- Footnotes
- F1, F2
DGX
transaction
Common Stock
Sale
- Transaction value
- $7,883,901
- Shares
- -41,004
- Change %
- -25%
- Price
- $192.27
- Shares after
- 125,227
- Date
- 25 Nov 2025
- Ownership
- Direct
- Footnotes
- F1, F3
DGX
transaction
Common Stock
Sale
- Transaction value
- $916,037
- Shares
- -4,747
- Change %
- -3.8%
- Price
- $192.97
- Shares after
- 120,480
- Date
- 25 Nov 2025
- Ownership
- Direct
- Footnotes
- F1, F4
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
DGX
transaction
Derivative
Non-Qualifed Stock Option (right to buy)
Options Exercise
- Transaction value
- $5,277,634
- Shares
- -55,093
- Change %
- -100%
- Price
- $95.80
- Shares after
- 0
- Date
- 25 Nov 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 55,093
- Exercise price
- $95.80
- Footnotes
- F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. |
| F2 | This transaction was executed in multiple trades at prices ranging from $190.810 to $191.805. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F3 | This transaction was executed in multiple trades at prices ranging from $191.820 to $192.810. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F4 | This transaction was executed in multiple trades at prices ranging from $192.820 to $193.310. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F5 | The options vested in three equal annual installments beginning on the first annual anniversary of the grant date. |